Changing Mindset and Treating Hereditary Angioedema with Normalization of Life as the Goal
December 9, 2023
December 9, 2024
This activity is jointly provided by P2P Syncro and Postgraduate Institute for Medicine.
This activity is supported in by an independent education grant from Takeda.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Contact Hour
- Physician Assistants — 1.0 CE Credit
- Pharmacists — 1.0 Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Healthcare providers in allergy and immunology, internal medicine, family medicine, pediatrics, genetics. Healthcare professionals caring for patients with hereditary angioedema.
Normalization of life is the recommended treatment goal for patients with hereditary angioedema (WAO/EAACI 2022). This program will discuss the disease burden that patients carry and the role of long-term prophylaxis in improving the quality of life of patients with hereditary angioedema.
Upon completion of this activity, participants should be able to:
- Recognize that disease burden is substantial and anxiety/depression is common in hereditary angioedema.
- Inquire about quality of life (QoL) at every patient’s visit and know the tools to evaluate the severity of the issue.
- Assess the role of long-term prophylactic therapies in improving QoL and achieving normalization of life.
John Anderson, MD
Dr. John Anderson is an allergy and immunology specialist at AllerVie Health in Alabama. He is a nationally recognized physician expert in the field of hereditary angioedema. He has published extensively on various topics of the disease.
Njeri Maina, MD PhD
Dr. Njeri Maina is an allergy and immunology specialist at Atlanta Allergy & Asthma in Geogia. Dr. Maina’s research interest includes the management of hereditary angioedema. Her work on the subject was published in peer-reviewed journals.
Amber Nelson, NP
Amber Nelson is a nurse practitioner at AllerVie Health in Alabama. She is experienced in caring for patients with hereditary angioedema. She advocates for her patients. She guides them through the treatment course. She helps them to achieve the best outcomes.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and P2P Syncro. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.
Pharmacy Continuing Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008162-9999-23-364-H01-P. Type of Activity: Knowledge.
Physician Assistant Continuing Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until December 9, 2024 . PAs should only claim credit commensurate with the extent of their participation
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
- John Anderson, MD
- Grant/Research Support: : CSL Behring, Takeda, Pharming, BioCryst, Kalvista, Pharvaris, Biomarin, Astria
- Consultant/Advisory Board: CSL Behring, Takeda, Pharming, BioCryst, Kalvista, Pharvaris, Ionis, Astria, Cycle Pharma
- Speakers Bureau/Honoraria for non-CME: CSL Behring, Takeda, Pharming. BioCryst
- Njeri Maina, MD
- Nothing to Disclose
- Amber Nelson, NP
- Nothing to Disclose
The PIM planners and others have nothing to disclose. The P2P Syncro planners and others have nothing to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be emailed to the participant.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Postgraduate Institute for Medicine (PIM) requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions please contact: [email protected].